e-learning
resources
Stockholm 2002
Monday 16.09.2002
Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ultrastructure of the pulmonary surfactant and its alterations after general inhibition of protein synthesis in the rat
M. Walski, R. Celary-Walska (Warsaw, Poland)
Source:
Annual Congress 2002 - Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Session:
Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Session type:
Oral Presentation
Number:
2333
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Walski, R. Celary-Walska (Warsaw, Poland). Ultrastructure of the pulmonary surfactant and its alterations after general inhibition of protein synthesis in the rat. Eur Respir J 2002; 20: Suppl. 38, 2333
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Late Breaking Abstract - The mortality predicting factors at admission and during hospitalisation of pateints with SARS COV2
Risk factors associated with the development of interstitial lung abnormalities
Related content which might interest you:
Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017
Oleic acid induces alveolar oedema by direct inhibition of the Na
+
,K
+
-ATPase in an intact isolated lung model
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
Effect of inhaled surfactant enriched with phosphatidylethanolamine on matrix deposition in a murine model of airway inflammation and remodeling.
Source: International Congress 2018 – Basic pharmacology
Year: 2018
The influence of intratracheal surfactant-BL administration or [DCquote]empty“ phosphatidylcholine liposomes on lung surfactant level and alveolar macrophage activity in intact rat lungs
Source: Eur Respir J 2003; 22: Suppl. 45, 73s
Year: 2003
Air space distension precedes spontaneous fibrotic remodeling and impaired cholesterol metabolism in the absence of surfactant protein C
Source: ERS Lung Science Conference 2020
Year: 2020
Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Involvement of the CD40-CD154 interaction in the regulation of surfactant production and development of secondary pulmonary alveolar proteinosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Low expression of cellular retinoic acid binding protein 2 and dysregulation of elastin expression in pulmonary emphysema fibroblasts
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat.
Source: Eur Respir J 2001; 18: 1081
Year: 2001
Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006
Glutathione synthesis in rat lungs: effect of growth and maturation
Source: Eur Respir J 2003; 22: Suppl. 45, 73s
Year: 2003
Influence of recombinant human vascular endothelium growth factor- (rhVEGF-) 165 on surfactant proteins (SPs) mRNA levels in emphysematous rat lungs
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Inhibition of napsin A induces proSP-B accumulation and ER-stress: a novel mouse model for lung fibrosis
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept